QA: BALCHEM CORP in us_medicinal_products/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2022_BALCHEM_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, BALCHEM CORP

  xvar xval
0 LiabilitiesNoncurrent 4,811,000
1 LiabilitiesCurrent 190,257,000
2 remainder_Liabilities 127,242,000
3 AssetsCurrent 322,232,000
4 AssetsNoncurrent 18,603,000
5 PropertyPlantAndEquipmentNet 237,517,000
6 Goodwill 618,614,000
7 remainder_Assets 2,359,000
8 GeneralAndAdministrativeExpense 657,997,000
9 ResearchAndDevelopmentExpense 13,524,000
10 remainder_Expenses 29,129,000
11 remainder_Revenues 799,023,000
12 remainder_NetIncome -2,269,000
13 remainder_ComprehensiveNetIncome -9,166,000
  yvar yval
0 Liabilities 322,310,000
1 Assets 1,199,325,000
2 Expenses 700,650,000
3 Revenues 799,023,000
4 StockholdersEquity 877,015,000
5 NetIncome 96,104,000
6 ComprehensiveNetIncome 91,521,000
7 BaseVar 1,516,371,500
8 EconomicCapitalRatio 1.10

Edgar->Model Mapping

Feature Distribution

Change over Time